GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Acro Biomedical Co Ltd (OTCPK:ACBM) » Definitions » Gross-Profit-to-Asset %

Acro Biomedical Co (Acro Biomedical Co) Gross-Profit-to-Asset % : 0.00% (As of Jun. 2023)


View and export this data going back to 2016. Start your Free Trial

What is Acro Biomedical Co Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Acro Biomedical Co's annualized Gross Profit for the quarter that ended in Jun. 2023 was $0.00 Mil. Acro Biomedical Co's average Total Assets over the quarter that ended in Jun. 2023 was $0.60 Mil. Therefore, Acro Biomedical Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Jun. 2023 was 0.00%.


Acro Biomedical Co Gross-Profit-to-Asset % Historical Data

The historical data trend for Acro Biomedical Co's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Acro Biomedical Co Gross-Profit-to-Asset % Chart

Acro Biomedical Co Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Sep19 Dec20 Dec21 Dec22
Gross-Profit-to-Asset %
Get a 7-Day Free Trial 82.03 10.58 15.38 29.56 19.48

Acro Biomedical Co Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 38.47 - -

Competitive Comparison of Acro Biomedical Co's Gross-Profit-to-Asset %

For the Medical Distribution subindustry, Acro Biomedical Co's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Acro Biomedical Co's Gross-Profit-to-Asset % Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Acro Biomedical Co's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Acro Biomedical Co's Gross-Profit-to-Asset % falls into.



Acro Biomedical Co Gross-Profit-to-Asset % Calculation

Acro Biomedical Co's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2022 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2022 )/( (Total Assets (A: Dec. 2021 )+Total Assets (A: Dec. 2022 ))/ count )
=0.141/( (0.761+0.687)/ 2 )
=0.141/0.724
=19.48 %

Acro Biomedical Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Jun. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Jun. 2023 )/( (Total Assets (Q: Mar. 2023 )+Total Assets (Q: Jun. 2023 ))/ count )
=0/( (0.657+0.539)/ 2 )
=0/0.598
=0.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Jun. 2023) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Acro Biomedical Co Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Acro Biomedical Co's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Acro Biomedical Co (Acro Biomedical Co) Business Description

Traded in Other Exchanges
N/A
Address
12175 Visionary Way, Suite 1160, Fishers, IN, USA, 46038
Acro Biomedical Co Ltd develops and manufactures nutritional products. The company offers cordyceps fungus for medicinal purposes. It also sells cordycepin and cordyceps powder.
Executives
Pao-chi Chu director, 10 percent owner, officer: CEO 2F, NO. 356 SEC 1. DUNHUA S. RD., DA'AN DISTRICT, TAIPEI CITY F5 106

Acro Biomedical Co (Acro Biomedical Co) Headlines

No Headlines